BCH: Solid Earnings Outlook in 2H21
We maintain HOLD rating and raise target price by 33% to Bt28 (Previous TP: Bt21.0) based on 33xPE’1H22E, which is close to 10-years average of...
161 Views
BCH: Strong Earnings Momentum in 2Q21
Positive tone from Tuesday analyst meeting thanks to solid COVID-19 related revenue from 3rd wave of COVID-19. We maintain HOLD rating and raise...
164 Views
BCH: 2Q20 Earnings Should Be the Bottom Quarter
Yesterday analyst meeting came out with a neutral tone. We expect 2Q20 earnings to be the bottom quarter, given full quarter impact from COVID-19...
314 Views
BCH: Positive Sentiment from New Rate Adjustment for SSO Patients
Yesterday's analyst meeting came out with a positive tone. We maintain our BUY rating with a target price of Bt21.0 based on DCF on the back of...
364 Views
BCH: Private Chain Hospital with High Sustainable Growth
We initiate coverage on BCH with a BUY rating, based on a target price of Bt21, which is derived from a DCF methodology (WACC 6.8% and terminal...
538 Views